Approvals/TGA/ICLUSIG ponatinib (as hydrochloride) 30 mg film-coated tablet bottle

Approved

STANDARD

ICLUSIG ponatinib (as hydrochloride) 30 mg film-coated tablet bottle

Takeda Pharmaceuticals Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: d02e947d4c7df119
Product Name: ICLUSIG ponatinib (as hydrochloride) 30 mg film-coated tablet bottle
Artg Id: 374492
Artg Name: ICLUSIG ponatinib (as hydrochloride) 30 mg film-coated tablet bottle
Sponsor: Takeda Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/takeda-pharmaceuticals-australia-pty-ltd
Artg Date: 2022-09-16
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2019-CMI-02146-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-PI-02267-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

d02e947d4c7df119

Type

Standard